Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril. [electronic resource]
Producer: 20050817Description: F359-68 p. digitalISSN:- 1931-857X
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Animals
- Blood Cell Count
- Blood Pressure -- drug effects
- Body Weight -- drug effects
- Disease Progression
- Drug Interactions
- Eating -- physiology
- Enalapril -- therapeutic use
- Fibronectins -- metabolism
- Fibrosis
- Glomerulosclerosis, Focal Segmental -- drug therapy
- Immunohistochemistry
- Immunosuppressive Agents -- therapeutic use
- Kidney Diseases -- drug therapy
- Kidney Function Tests
- Male
- Mycophenolic Acid -- analogs & derivatives
- Nephrectomy
- Plasminogen Activator Inhibitor 1 -- biosynthesis
- Proteinuria -- drug therapy
- Rats
- Rats, Wistar
- Thy-1 Antigens -- immunology
- Transforming Growth Factor beta -- metabolism
- Transforming Growth Factor beta1
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.